A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2

scientific article published on 01 March 2001

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00002371-200103000-00014
P698PubMed publication ID11265777

P50authorSteven RosenbergQ2347448
P2093author name stringWitebsky FG
Steinberg SM
Marincola FM
Mavroukakis SA
Goodwin RS
McIntyre LS
Seipp CA
Ohnmacht GA
Morton KE
Phan GQ
Muehlbauer PM
Shea YR
Rogers-Freezer LJ
P433issue2
P921main subjectplacebo-controlled trialQ108853737
nystatinQ251005
placeboQ269829
P304page(s)188-192
P577publication date2001-03-01
P1433published inJournal of ImmunotherapyQ15763946
P1476titleA prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2
P478volume24

Reverse relations

cites work (P2860)
Q24244555Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Q24187300Immunotherapy for advanced renal cell cancer
Q24246777Immunotherapy for advanced renal cell cancer
Q24243046Interventions for preventing oral mucositis for patients with cancer receiving treatment
Q24246310Interventions for preventing oral mucositis for patients with cancer receiving treatment

Search more.